Obstetrics - Prematurity Flashcards
Incidence of PPROM
3% of all pregnancies
Primary investigations for PPROM
Nitrazine, ferning test, AFI (if fluid not visible)
93% sensitivity
Second line investigation for PPROM
PAMG-1
GBS swab should be done for PPROM if not done within last
5 weeks
risk of recurrence of PPROM
10-32%
Risk of PTL in future pregnancy after PPROM
34-46%
subclinical infection in ___% of PPROM
50%
___% of PPROM proceed to PTL
70%
50% of PPROM deliver within
one week
PPROM relationship with PTB
PPROM causes 1/3 of all PTL
PTB incidence
8% of all births
___% of PPROM will have pooling of amniotic fluid in vaginal vault
60%
FN rate for pooling of fluid (PPROM)
12%
pH required for nitrazine + in PPROM
7.0-7.3
Gold standard for equivocal PPROM
amnio + carmine dye infusion
(not routinely performed)
pH of vagina
3.8 - 4.2
Initial assessment of maternal wellbeing in PPROM
HR, BP, Temp
Symptoms
Bloods (WBC)
Initial assessment of fetus in PPROM
EFM
USS
- presentation,
- biometry,
- placental location,
- AFI/DVP,
- Cx length,
- BPP if >28/40
Contraindications to expectant management in PPROM
1) active labour
2) evidence of infection
3) abruption
4) cord prolapse
5) abnormal CTG or USS
antibiotic options in PPROM
1)
a macrolide (erythromycin, azithromycin, or clarithromycin) alone or associated with GBS coverage for 2 days (if GBS status is unknown or positive), or
2)
a combination of ampicillin/amoxicillin and a macrolide independently of GBS status.
PPROM Erythromycin dose (oral)
250mg PO QDS x 10/7
PPROM Erytromycin dose (IV/PO)
250mg IV QDS x 2/7, then 333mg PO TDS x 5/7
PPROM Azithromycin dose
1g PO single dose
(or 500mg PO stat, then 250mg PO daily x 4/7)
PPROM Clarithromycin dose
500mg PO BD x 7/7
PPROM GBS coverage
Ampicillin 2g IV QDS x 2/7
or
Amoxicillin 500mg PO TDS x 5/7
or
PenG 5 MU IV, then 2.5–3.0 MU every 4 h for 2 d